25 May 2013
Keywords: novogen, granted, fast-track, status, marshall, edwards, subsidiary
Article | 28 February 2005
Marshall Edwards, the US subsidiary of Australian pharmaceutical company Novogen, has been granted fast-track status by the U.S. Food ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 February 2005
24 May 2013
© 2013 thepharmaletter.com